放射治疗和CAR-T的有效组合 - 一个系统的审查
Wojciech Szlasa1, Aleksandra Sztuder2, Agnieszka Kaczmar-Dybko3
1Lower Silesian Centre of Oncology, Pulmonology and Hematology, Wroclaw 53-413, Poland; Medical University Hospital, Borowska 213, Wrocław 50-556, Poland.
概括
放射治疗 (RT) 通过调节瘤微环境并改善免疫细胞透,增强了固体瘤的仿真抗原受体T (CAR-T) 细胞疗法. 这种组合显示出改善癌症治疗结果的协同潜力.
科学领域:
- 免疫治疗是一种免疫疗法.
- 辐射瘤学 辐射瘤学
- 癌症生物学 癌症生物学
背景情况:
- 化学抗原受体T (CAR-T) 细胞疗法显示出希望,但在固体瘤中面临挑战,包括不良的贩运和有限的持久性.
- 瘤微环境 (TME) 通常会阻碍有效的CAR-T细胞功能.
- 放射治疗 (RT) 是一种标准的癌症治疗方法,它会损害癌细胞,并会影响免疫反应.
研究的目的:
- 探索结合CAR-T细胞治疗与放射治疗 (RT) 的协同潜力.
- 审查RT可以增强固体瘤中CAR-T细胞疗效的分子机制.
- 讨论创新策略和优化联合CAR-T和RT治疗的考虑因素.
主要方法:
- 对CAR-T细胞治疗和放射治疗现有文献的综述.
- 对RT对TME和免疫细胞影响的分子机制的分析.
- 结合CAR-T和RT的临床策略的评估,包括时间和剂量.
主要成果:
- RT调节TME,增加抗原呈现,并促进免疫细胞透,支持CAR-T细胞活性.
- RT诱导免疫细胞死亡并改变瘤层,促进T细胞的招募.
- 创新策略,比如将低分离RT与骨髓系衍生抑制细胞阻断结合起来,有望提高CAR-T疗法的效果.
结论:
- CAR-T细胞治疗和RT的结合为治疗固体瘤提供了显著的协同潜力.
- 了解RT诱导的分子变化对于优化CAR-T细胞治疗至关重要.
- 考虑到时间和剂量,RT的战略应用可以提高CAR-T细胞的疗效,特别是在血液性恶性瘤和潜在的固体瘤中.
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K